Deborah Mance is currently the Executive Business Director for Alzheimer's Disease at Eli Lilly and Company, a position held since 2021. Previously, they held various roles at Biogen Idec, Lilly USA, LLC, Horizon Pharma, Genetics Institute, and MedImmune, focusing on business strategy and reimbursement management in the healthcare sector. Deborah earned a Master of Business Administration from Virginia Commonwealth University in 2019 and is a Certified Professional Coder, with ongoing education at the American Academy of Professional Coders and The University of Tennessee at Chattanooga.
This person is not in the org chart
This person is not in any teams
This person is not in any offices